The Chirp Issue #7

Imagine a future where your healthcare is tailored specifically to your unique needs and characteristics. Precision medicine and personalized healthcare are paving the way for a new era of individualized treatments, promising improved health outcomes, minimized risks, and a revolution in how diseases are diagnosed, treated, and prevented. But as we embark on this transformative journey, we must navigate challenges to ensure equitable access, privacy, and the seamless integration of these groundbreaking approaches into our healthcare systems.

Discover the potential and hurdles of precision medicine and personalized healthcare as we delve into the exciting world of tailored medicine today.

Personal & Precise

Precision Medicine and the Future of Healthcare

Watch this video for a primer in precision medicine. While traditional medicine has a “one size fits all” approach, precision medicine seeks to deliver the right treatment to the right patient at the right time. While this approach requires large amounts of data, AI can be used to analyze huge datasets of patient data, including genetic information and medical history. The video gives a number of realistic applications for this information in treatments and drug development.

How Personalized Medicine will transform healthcare by 2030

Personalized medicine is a healthcare approach that takes into account individual patient characteristics, such as genetics, lifestyle, and environment, to deliver the most effective and efficient treatment. This article provides a thoughtful and comprehensive overview of the potential of personalized medicine to transform healthcare by 2030. The authors argue that personalized medicine leads to improved effectiveness of diagnostics, treatment and prevention, added economic value, and equitable access for all.

An introductory guide to biomarkers, precision, personalised and stratified medicine

This article emphasizes the importance of biomarkers in precision, personalized, and stratified medicine, covering qualitative and quantitative biomarkers that include DNA, proteins, and imaging. The article also explains the roles of prognostic and predictive biomarkers in estimating patient outcomes and treatment benefits. Read it to learn more about the analytical and clinical validation of biomarkers and understand the necessity of technical robustness and clinical applicability.


New at Canary Speech

Canary in the news

We’ve had an exciting month, so you may want to check out the latest at Canary. In May we launched with Galvan and became a Microsoft Cloud for Healthcare partner (see also herehere, and here). In June we partnered with Hackensack Meridian Health. Keep abreast of all our news by following us on LinkedIn and subscribing to this newsletter.

Microsoft Cloud for Healthcare Rollout

We are looking for a limited group of 10 partners to be part of our special program pricing. Microsoft chose Canary because we are innovative, accessible, secure, and equitable. Want to learn more? Email


Want to learn more about how we screen for behavioral health using vocal biomarkers? Contact us:, (801) 369-8408